Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amyl 3 Chloro 4 Oxoacetate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112979461A reveals a continuous flow method for 3-chloro-4-oxoacetic acid amyl ester, offering higher yields and safer manufacturing for vitamin B1 intermediates.